22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has secured the consent of its senior lender under the terms of its Senior Secured Credit Facility for the previously announced sale of its GVB Biopharma ("GVB") hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada...
2023-12-14 4:05 PM EST
22nd Century Group Launches New Private Label Brand with Top U.S. C-Store Chain
Line with Recent Expectations Buffalo, New York--(Newsfile Corp. - April 18, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that it has commenced sales under a new manufacturing agreement...
2023-04-18 7:00 AM EDT
22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown
CigarettesBuffalo, New York--(Newsfile Corp. - January 18, 2023) - 22nd Century Group, Inc. (Nasdaq: XXII), the world's leading biotechnology company dedicated to improving health with reduced nicotine tobacco and advanced plant technologies in both hemp/cannabis and hops, today announced new distribution partnerships with Core-Mark International and Eby-Brown Company, two...
2023-01-18 9:25 AM EST
FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers
Billion U.S. Menthol Market FDA to Advance Reduced Nicotine Content Standards for All Combustible Cigarettes in Q4 2023Paradigm Shift in Tobacco Health Policy and Regulation Expected to Generate Major Gains for Public HealthBuffalo, New York--(Newsfile Corp. - January 17, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops...
2023-01-17 9:00 AM EST
22nd Century Group (XXII) Comments on the Advancement of New Zealand's National Reduced Nicotine Content Law
Including the United StatesBuffalo, New York--(Newsfile Corp. - December 13, 2022) - 22nd Century Group, Inc. (NASDAQ: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technologies, today commented on the...
2022-12-13 9:25 AM EST
22nd Century Group Provides Update on Grass Valley Facility
Buffalo, New York--(Newsfile Corp. - December 8, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today provided updates on its operational recovery progress and customer shipments following a fire that occurred at its distillate and isolate manufacturing facility located in Grass Valley, Oregon, on November 20, 2022. The Company has opened a new logistics hub at an existing company facility in nearby Tygh Valley, OR and production space nearby in an existing lab facility...
2022-12-08 1:00 PM EST
22nd Century Group Provides Update on Incident at Grass Valley Facility
Buffalo, New York--(Newsfile Corp. - November 21, 2022) - GVB Biopharma, a 22nd Century Group company (NASDAQ: XXII), today announced that a fire occurred at its GVB Biopharma distillate and isolate manufacturing facility located in Grass Valley, Oregon, on November 20, 2022. There were no reported life threatening injuries, but the fire damaged the facility."We want to thank the first responders who were able to quickly contain the fire and prioritize the safety of local residents during...
2022-11-21 4:10 PM EST